Dermapharm AG is a prominent pharmaceutical company based in Gruenwald, Germany, specializing in the development and manufacturing of high-quality generic and specialty medications. The company focuses on various therapeutic areas, including oncology, neurology, and infectious diseases, leveraging advanced research and technology to enhance patient care. Dermapharm is committed to innovation and quality, ensuring that its products meet rigorous standards while addressing the evolving needs of healthcare providers and patients across diverse markets.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

11 Patents

#1 in Gruenwald

#3,524 in Germany

#51,801 in the World

Gruenwald, Germany

Dermapharm Ag

Forward Citations = 53

10 inventors:

Alexander Grimm (4 out of 4 patents)

Daniel Bünger Von Wurmb (3 out of 3 patents)

Camill Maier (2 out of 2 patents)

4. Ingo Aldag (1 out of 3 patents)

5. Daniel Bünger (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Dermapharm Ag. Retrieved from https://idiyas.com/company/dermapharm-ag

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

6 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]